Company / Operating Margin
InMed Pharmaceuticals Inc. Operating Margin History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-1707.3%
FY2023
5-year range
-1707.3% / -936.6%
FY2022-FY2023
Trend
-82.3%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-1707.3% in FY2023.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2023, operating margin decreased 82.3% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | -1707.3% | -82.3% |
| FY2022 | -936.6% | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026